Study of LW402 in Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07186387 · COMPLETED
Trial details
- NCT number
- NCT07186387
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2024-09-25
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.